{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:33:25Z","timestamp":1758274405789,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228"],"award-info":[{"award-number":["82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228","82270228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science, Technology& Innovation Project of Xiongan New area","award":["2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004"],"award-info":[{"award-number":["2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004","2023XACX0004"]}]},{"name":"Peking University People\u2019s Hospital Research and Development Funds","award":["RDL2021-01","RDL2021-01","RDL2021-01","RDL2021-01","RDL2021-01"],"award-info":[{"award-number":["RDL2021-01","RDL2021-01","RDL2021-01","RDL2021-01","RDL2021-01"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1103304","2022YFA1103304","2022YFA1103304","2022YFA1103304","2022YFA1103304","2022YFA1103304"],"award-info":[{"award-number":["2022YFA1103304","2022YFA1103304","2022YFA1103304","2022YFA1103304","2022YFA1103304","2022YFA1103304"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484235","20220484235","20220484235","20220484235","20220484235"],"award-info":[{"award-number":["20220484235","20220484235","20220484235","20220484235","20220484235"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00277-024-05827-4","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:01:52Z","timestamp":1718132512000},"page":"3723-3735","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"103","author":[{"given":"Xie","family":"Juan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunhong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-nan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"issue":"2","key":"5827_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1172\/JCI121127","volume":"130","author":"S Prockop","year":"2020","unstructured":"Prockop S et al (2020) Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. J Clin Invest 130(2):733\u2013747","journal-title":"J Clin Invest"},{"issue":"2","key":"5827_CR2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1128\/JVI.01777-06","volume":"81","author":"IY Pappworth","year":"2007","unstructured":"Pappworth IY, Wang EC, Rowe M (2007) The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol 81(2):474\u2013482","journal-title":"J Virol"},{"issue":"2","key":"5827_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/JVI.01932-15","volume":"90","author":"LR Williams","year":"2016","unstructured":"Williams LR et al (2016) Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle. J Virol 90(2):947\u2013958","journal-title":"J Virol"},{"issue":"2","key":"5827_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","volume":"129","author":"H Williams","year":"2005","unstructured":"Williams H et al (2005) The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol 129(2):266\u2013274","journal-title":"Br J Haematol"},{"issue":"16","key":"5827_CR5","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","volume":"124","author":"T Azzi","year":"2014","unstructured":"Azzi T et al (2014) Role for early-differentiated natural killer cells in infectious mononucleosis. Blood 124(16):2533\u20132543","journal-title":"Blood"},{"issue":"2","key":"5827_CR6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/eji.201141832","volume":"42","author":"S Wiesmayr","year":"2012","unstructured":"Wiesmayr S et al (2012) Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD. Eur J Immunol 42(2):541\u2013550","journal-title":"Eur J Immunol"},{"issue":"13","key":"5827_CR7","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1182\/blood.2022017650","volume":"141","author":"H Vietzen","year":"2023","unstructured":"Vietzen H et al (2023) HLA-E-restricted immune responses are crucial for the control of EBV infections and the prevention of PTLD. Blood 141(13):1560\u20131573","journal-title":"Blood"},{"key":"5827_CR8","doi-asserted-by":"crossref","unstructured":"Hsieh WC et al (2021) NK cell receptor and ligand composition influences the clearance of SARS-CoV-2. J Clin Invest 131(21):e146408","DOI":"10.1172\/JCI146408"},{"issue":"4","key":"5827_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00262-015-1750-0","volume":"65","author":"AR Manser","year":"2016","unstructured":"Manser AR, Uhrberg M (2016) Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance. Cancer Immunol Immunother 65(4):417\u2013426","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"5827_CR10","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.4049\/jimmunol.1002732","volume":"186","author":"CT Lutz","year":"2011","unstructured":"Lutz CT et al (2011) Human NK cells proliferate and die in vivo more rapidly than T cells in healthy young and elderly adults. J Immunol 186(8):4590\u20134598","journal-title":"J Immunol"},{"issue":"4","key":"5827_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000328005","volume":"3","author":"I Gayoso","year":"2011","unstructured":"Gayoso I et al (2011) Immunosenescence of Human Natural Killer Cells. J Innate Immun 3(4):337\u2013343","journal-title":"J Innate Immun"},{"issue":"5","key":"5827_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00281-020-00824-x","volume":"42","author":"W Xu","year":"2020","unstructured":"Xu W et al (2020) The untwining of immunosenescence and aging. Semin Immunopathol 42(5):559\u2013572","journal-title":"Semin Immunopathol"},{"issue":"2","key":"5827_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.humimm.2016.11.006","volume":"78","author":"MT Phan","year":"2017","unstructured":"Phan MT et al (2017) Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity. Hum Immunol 78(2):103\u2013112","journal-title":"Hum Immunol"},{"issue":"10","key":"5827_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/bmt.2008.386","volume":"43","author":"J Styczynski","year":"2009","unstructured":"Styczynski J et al (2009) Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 43(10):757\u201370","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"5827_CR15","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/eji.201948375","volume":"50","author":"XY Zhao","year":"2020","unstructured":"Zhao XY et al (2020) Expanded clinical-grade membrane-bound IL-21\/4-1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo. Eur J Immunol 50(9):1374\u20131385","journal-title":"Eur J Immunol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05827-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:13:55Z","timestamp":1724836435000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05827-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5827"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05827-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"23 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All patients and donors provided written informed consent before their entry into the study in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}},{"value":"There are no conflict of interest exits in the submission of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The human study and animal experiments were both approved by the Ethics Committee of Peking University People's Hospital.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement for human and\/or animal studies"}}]}}